Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11529405 MDR

Patent 11529405 was granted and assigned to Janssen Pharmaceuticals on December, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 25 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Apr, 2023
Infobox
Patent Citations
‌
US Patent 10940191 MDR
0
Edits on 23 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 23 Apr, 2023
Edits on 2 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 2 Apr, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
Janssen Pharmaceuticals
Janssen Pharmaceuticals
0
Current Assignee
Janssen Pharmaceuticals
Janssen Pharmaceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
115294050
Date of Patent
December 20, 2022
0
Patent Application Number
171675950
Date Filed
February 4, 2021
0
Patent Citations
‌
US Patent 10150952 Compositions and methods for protein glycosylation
0
‌
US Patent 10159751 ExPEC glycoconjugate vaccine formulations
0
‌
US Patent 10206992 MDR
0
‌
US Patent 10441647 Polysaccharide and uses thereof
0
‌
US Patent 10525145 ExPEC glycoconjugate vaccine formulations
0
‌
US Patent 10577592 Compositions and methods for protein glycosylation
0
‌
US Patent 10583185 Methods and compositions for immune protection against extra-intestinal pathogenic
0
‌
US Patent 10940191 MDR
0
‌
US Patent 10940192 Polysaccharide and uses thereof
0
‌
US Patent 11015177 Compositions and methods for protein glycosylation
0
‌
US Patent 11033633 ExPEC glycoconjugate vaccine formulations
0
Patent Primary Examiner
‌
Brian Gangle
0
Edits on 26 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Mar, 2023
Edits on 24 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 24 Mar, 2023
Edits on 22 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 22 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 21 Mar, 2023
Infobox
Patent Citations
‌
US Patent 10206992 MDR
0
Edits on 21 Dec, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 21 Dec, 2022
Edits made to:
Infobox (+20 properties)
Article (+114 characters)
‌

 US Patent 11529405 MDR

Article

The subject relates to an isolated antibody that specifically binds to O25b antigen of multi drug resistant (MDR)

Infobox
Is a
Patent
Patent
0
Patent Applicant
Janssen Pharmaceuticals
Janssen Pharmaceuticals
0
Current Assignee
Janssen Pharmaceuticals
Janssen Pharmaceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
115294050
Date of Patent
December 20, 2022
0
Patent Application Number
171675950
Date Filed
February 4, 2021
0
Patent Citations
‌
US Patent 10150952 Compositions and methods for protein glycosylation
0
‌
US Patent 10159751 ExPEC glycoconjugate vaccine formulations
0
‌
US Patent 10206992 MDR
0
‌
US Patent 10441647 Polysaccharide and uses thereof
0
‌
US Patent 10525145 ExPEC glycoconjugate vaccine formulations
0
‌
US Patent 10577592 Compositions and methods for protein glycosylation
0
‌
US Patent 10583185 Methods and compositions for immune protection against extra-intestinal pathogenic
0
‌
US Patent 10940191 MDR
0
‌
US Patent 10940192 Polysaccharide and uses thereof
0
‌
US Patent 11015177 Compositions and methods for protein glycosylation
0
‌
US Patent 11033633 ExPEC glycoconjugate vaccine formulations
0
Patent Primary Examiner
‌
Brian Gangle
0

Find more entities like US Patent 11529405 MDR

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo